QNRX – quoin pharmaceuticals, ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies [Yahoo! Finance]
Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form EFFECT Quoin Pharmaceuticals,
Form 4 Quoin Pharmaceuticals, For: Dec 01 Filed by: Lawlor Sally Bridget
Form 8-K Quoin Pharmaceuticals, For: Nov 14
Form 8-K Quoin Pharmaceuticals, For: Nov 11
Form S-3 Quoin Pharmaceuticals,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.